Panacea Biotec Limited — Others, 01-04-2025: Change in Management

Mr. Sunil Anand, Associate Director - Finance & Corporate Affairs, has superannuated from Panacea Biotec after over 20 years of service, effective March 31, 2025. His departure marks a significant transition in the company's senior management, given his long-standing contributions to growth and strategy. This change may prompt the company to assess its leadership structure and potentially seek fresh talent to fill the gap. For investors, this departure could introduce uncertainties regarding operational continuity but may also present opportunities for strategic rejuvenation. Overall, the outlook remains cautiously optimistic as the company navigates this leadership transition.